Subsidiaries and Holdings
Transgene has a wholly owned subsidiary in the United States, Transgene, Inc., located in Cambridge, Massachusetts. This subsidiary represents Transgene S.A. before various bodies, regulatory authorities and clinical sites for clinical trials that it conducts in the United States.
Transgene Tasly (Tianjin) Biopharmaceutical Co. Ltd. is a Chinese company, founded in 2010 to develop and ultimately sell biotechnology products, including those of Transgene, in China. It is jointly owned with Tasly Pharmaceuticals Group, based in Tianjin, China.
ElsaLys Biotech SAS was founded in 2013 by former Transgene executives to develop monoclonal antibodies. Transgene participated in its first financing round.